ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: 2405
    Machine Learning in SLE Diagnosis: Performance of the SLE Risk Probability Index Questionnaire in a Multicenter Cohort of Patients with Systemic Lupus Erythematosus
  • Abstract Number: 0844
    Machine Learning Model Incorporating Baseline and Early Follow-up Clinical Data Predicts 52-Week Cutaneous Outcomes in Systemic Sclerosis
  • Abstract Number: 2406
    Machine Learning-Based Artificial Intelligence in Systemic Lupus Erythematosus: A Systematic Review of Outcome Prediction and Patient Stratification
  • Abstract Number: 1953
    Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns
  • Abstract Number: 0329
    Machine Learning-Based Model to Predict Rapid Structural Progression in Knee Osteoarthritis
  • Abstract Number: 2007
    Machine Learning-Based Prediction of Gout Onset in Individuals with Asymptomatic Hyperuricemia Using a Common Data Model
  • Abstract Number: 0845
    Machine Learning–Based Skin Transcriptome Classifier (v2.0) Links SSc Molecular Subtypes to Disease Severity and Progression
  • Abstract Number: 1515
    Machine Learning–Defined Subtypes of Systemic Lupus Erythematosus Identify Distinct Immunologic and Molecular Signatures
  • Abstract Number: 0423
    Macrophage activation syndrome-associated proteins and enhanced interferon gamma responsiveness characterize the plasma proteome of patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in a pre-treatment replication single center cohort
  • Abstract Number: 1765
    Maintenance of remission with rituximab versus azathioprine in newly diagnosed or relapsing eosinophilic granulomatosis with polyangiitis. A prospective, randomized, controlled, double-blind trial
  • Abstract Number: 0885
    MAIT cell-mediated immune modulation in lupus: antigen-driven expansion as a protective strategy
  • Abstract Number: 1680
    Major salivary gland ultrasonographic features of lymphoma and high lymphoproliferative risk lesions in Sjögren’s Disease: a systematic review
  • Abstract Number: 0706
    Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study
  • Abstract Number: 2264
    Male Sex and Obesity Are Risk Factors for Sarcopenia in RA: Korea National Health and Nutrition Survey 2008–2011
  • Abstract Number: 2045
    Malignancy in Behçet’s Syndrome: A 24-Year Cohort Study In a Non-Endemicand Multiethnic Country
  • Abstract Number: 0227
    Malignancy Screening of Dermatomyositis Patients in the Penn State Registry of Inflammatory Myopathies (PRIMO)
  • Abstract Number: 1650
    Malondialdehyde-Acetaldehyde and Citrulline Modified Proteins are Overexpressed in Cardiac Tissues in Rheumatoid Arthritis-Associated Heart Failure and Mediate Endothelial Cell Dysfunction
  • Abstract Number: 2031
    Management of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases: A Comparison of Rheumatologist and Pulmonologist Perspectives
  • Abstract Number: 2548
    Management of Uncontrolled Gout Among Rheumatologists: Findings from a Medical Chart Audit
  • Abstract Number: 1788
    Manganese-associated Single-nucleotide Polymorphisms are Associated with Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project
  • Abstract Number: 1424
    Mapping Central Nervous System Responses To Painful Stimuli In Patients With Axial Spondyloarthritis
  • Abstract Number: 1904
    Mapping CTD-ILD in a Spanish Cohort – the NIRRVANA Registry
  • Abstract Number: 0956
    Mapping Metabolic Changes in Skin Fibrosis in Systemic Sclerosis by Spatial Proteomics
  • Abstract Number: 2407
    Mapping Neurological Involvement, Regional Disparities, and Moderators of the Central Nervous System in Adult-Onset Systemic Lupus Erythematosus: A Global Systematic Review and Meta-Analysis
  • Abstract Number: 1782
    Mapping The Synovial Innervation Of The Human Knee Joint
  • Abstract Number: 0627
    Marked Decline in SLE Mortality Despite Rising Mortality in the General Population During the COVID-19 Pandemic
  • Abstract Number: 1809
    Mass Spectrometry-Based N-Terminomics Uncovers Proteolytic Signatures and Pathways in Juvenile Idiopathic Arthritis Synovial Fluid
  • Abstract Number: PP05
    Mastering a Rare, Autoimmune Disease: My Journey Regaining Agency Through Education, Collaboration, and Community
  • Abstract Number: 2211
    Maternal Adverse Pregnancy Outcomes and Risk Factors in Patients with Systemic Lupus Erythematosus in the United States
  • Abstract Number: 2203
    Maternal and Fetal Outcomes Associated with IL-17 Inhibitor Exposure During Pregnancy in Patients with Seronegative Arthritis: A Case Series of Nine
  • Abstract Number: 0427
    Maternal Smoking During Pregnancy and Risk of Juvenile Idiopathic Arthritis (JIA): Triangulating Evidence from Polygenic Risk Scores and Meta-Analysis in Scandinavian Birth Cohorts
  • Abstract Number: 2632
    Maternal vascular malperfusion: association with adverse perinatal outcomes in lupus pregnancies
  • Abstract Number: 2457
    Maternal, Embryo-Fetal And Neonatal Outcomes Following Belimumab Exposure During Pregnancy In Patients With Systemic Lupus Erythematosus
  • Abstract Number: 1801
    Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype
  • Abstract Number: PP04
    MCTD and Aging – Resilience Required
  • Abstract Number: 1216
    Measurement Properties of a Shorter Health Assessment Questionnaire (HAQ-II) in Patients with Inflammatory Myopathies
  • Abstract Number: 1357
    Measuring Rheumatoid Arthritis Outcomes Using Machine Learning Imputed Disease Activity Scores
  • Abstract Number: 0947
    Mechanisms of anti-NMDAR antibody-mediated neuronal pathology and mitigation by angiotensin II signaling inhibition
  • Abstract Number: 2197
    Mechanisms of Fetal Growth Restriction in Rheumatologic Autoimmune Diseases: Insights into Placental Pathology and Immune Dysregulation
  • Abstract Number: 2135
    Medication Use and Disease Activity in Systemic Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
  • Abstract Number: 2207
    Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis
  • Abstract Number: 0451
    Menopause Status and Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 1511
    Mental Health and Medical Burden:  The Impact of Depression on Length of Stay in Lupus Patients
  • Abstract Number: 1276
    Mental Health Screening Implementation for Pediatric Rheumatology Patients at a Tertiary Academic Medical Center
  • Abstract Number: 1592
    Mepolizumab to Benralizumab Switch in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • Abstract Number: 0968
    Mesenchymal Stromal Cells in Systemic Sclerosis are Dysfunctional and Have a Profibrotic and Senescent Phenotype
  • Abstract Number: 0187
    Message Testing in Online Recruitment Advertisements for a National Rheumatoid and Psoriatic Arthritis Study
  • Abstract Number: 0034
    Meta-Analysis of GWAS data from 10,003 Sjögren’s Disease Cases Identifies Thirteen Sjögren’s Risk Loci.
  • Abstract Number: 0031
    Meta-Analysis of Trans-Disease Microbial Biomarkers of Protection and Pathogenesis in Autoimmune Conditions: Results from the AMP AIM Consortium
  • Abstract Number: 2608
    Metabolic dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factors, and Cardiac Manifestations in Psoriasis
  • Abstract Number: 2303
    Metabolic impact of low dose IL‐2 therapy for primary Sjögren’s Disease in a double‐blind, randomized clinical trial
  • Abstract Number: 0322
    Metabolites Reflective of the Gut Microbiome Relate to Future Incident Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 2002
    Methods to Address Survival Bias and Competing Risks in Estimating the Causal Risks of Gout on Dementia Risk
  • Abstract Number: 2115
    METHOFRACT, a methotrexate osteopathy multicentric binational cohort study.
  • Abstract Number: 2576
    Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH) Study: Anti-inflammatory cytokine signals related to decreased arthritis disease activity over time
  • Abstract Number: 2682
    Methotrexate use and higher age impair humoral response against the recombinant herpes zoster vaccine (RZV) in Rheumatoid Arthritis: a prospective, randomized, placebo-controlled trial
  • Abstract Number: 0891
    MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial.
  • Abstract Number: 2429
    mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial
  • Abstract Number: 1119
    Microbial activation of cytotoxic CD8⁺ T cells promotes skin immune-related adverse events in patients treated with immune checkpoint inhibitors
  • Abstract Number: 0054
    Microbial Cues Promote Arthritis and Alter T Cell Selection in SKG Mice
  • Abstract Number: 2643
    Microbiome Signatures in RA Treatment: Personalizing Methotrexate Therapy
  • Abstract Number: 0800
    Microbiota-Derived Indole Promotes Collagen-Induced Arthritis Type-17 Immunity through Intestinal Dendritic Cell Cytokine Production
  • Abstract Number: 2501
    Microvascular dysfunction contributes to hand bone deterioration in SSc patients
  • Abstract Number: 1332
    Mid‐Infrared Spectroscopy for Enhanced Diagnosis of Rheumatic Diseases
  • Abstract Number: 1051
    Mitigating Hydroxychloroquine (HCQ) Nonadherence by Clarifying Misbeliefs Using a Shared Decision-Making Tool (HCQ-SAFE©) Across Two Different Rheumatology Centers
  • Abstract Number: 1864
    Mitochondrial Dysfunction Drives cGAS-STING–Mediated Type I Interferon Production and Fibrosis in Systemic Sclerosis
  • Abstract Number: 2443
    Mitochondrial dysfunction drives natural killer cell dysfunction in systemic lupus erythematosus
  • Abstract Number: 1011
    Model-based Evaluation of the Potential Public Health Impact of Expanding Medicare Coverage for Weight Loss Medications for Beneficiaries with Knee Osteoarthritis and Obesity in the US.
  • Abstract Number: 1780
    Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts
  • Abstract Number: 0454
    Models to predict flare and sustained remission in Rheumatoid Arthritis patients on optimization treatment with bDMARDs: clinical and molecular insights
  • Abstract Number: 0553
    Modified A-Tool: An online self-screening tool for axial spondyloarthritis for patients with chronic back pain
  • Abstract Number: 1141
    Modulation of Inflammatory Responses by Dental Pulp Stem Cell Extracellular Vesicles in Monosodium Urate-Stimulated Macrophages
  • Abstract Number: 1442
    Modulation of Soluble Biomarkers of Cartilage and Bone Turnover and Inflammation by Zasocitinib (TAK-279), an Oral, Allosteric, Highly Selective and Potent TYK2 Inhibitor, is Associated with Clinical Response in Patients with Active Psoriatic Arthritis
  • Abstract Number: 2351
    Modulation of Tyrosine Kinase 2- and Disease-Related Biomarkers by Zasocitinib (TAK-279), an Oral, Allosteric, Highly Selective and Potent Tyrosine Kinase 2 Inhibitor, Is Associated With Clinical Response in Patients with Active Psoriatic Arthritis
  • Abstract Number: 1367
    Molecular Signature Response Classifier Identifies Contribution of GLP-1 Therapy to TNF Inhibitor Response in Rheumatoid Arthritis Patients
  • Abstract Number: 0795
    Molecular Stratification of Rheumatoid Arthritis Patients by Multi-Omics Integration Reveals Disease Status and Predictors of Therapeutic Response
  • Abstract Number: 0047
    Monocyte Transcriptomic Signatures Uncover Potential Pathogenic Mechanisms of the APOL1 High Risk Genotype (HRG)
  • Abstract Number: 2540
    Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Clinical Marker of Gastrointestinal Involvement in Behçet Syndrome
  • Abstract Number: 0237
    Monogenic autoinflammatory diseases and undefined autoinflammatory syndrome in Western Mediterranean adults: clinical, genetic, and therapeutic insights
  • Abstract Number: 0817
    More than 40% of Older Adults with Rheumatic Diseases Are Prescribed Opioid Medications
  • Abstract Number: 1718
    Mortality and Hematological Adverse Events in Patients with Cancer Receiving Immune Checkpoint Inhibitors: Impact of Pre-existing Systemic Lupus Erythematosus
  • Abstract Number: 0849
    Mortality and Major Adverse Cardiac Events (MACE) with GLP-1 Receptor Agonists in Psoriatic Arthritis
  • Abstract Number: 0150
    Mortality in Anca-associated Vasculitis
  • Abstract Number: 1200
    Mortality in Idiopathic Inflammatory Myopathy in the Toulouse cohort (MIIRTALITY)
  • Abstract Number: 1024
    Mortality In Progressive Pulmonary Fibrosis Associated to Autoimmune Diseases: NEREA Registry
  • Abstract Number: 2113
    Mortality rate in patients with hip fracture: is it recommendable to establish fracture units?
  • Abstract Number: 0235
    Mortality Trends due to Hypertension Related Deaths in Elderly Patients with Inflammatory Polyarthropathy: A CDC WONDER Analysis of 21 Years
  • Abstract Number: 2516
    Mortality Trends in Primary Systemic Vasculitis in the United States (1999–2023)
  • Abstract Number: 1328
    Mortality Trends of Hypertension in Patients with Rheumatoid Arthritis in the United States (1999–2020)
  • Abstract Number: 1989
    Moving Out of the Kid’s Rheum: Transitioning Young Adult Patients from Pediatric to Adult Rheumatology Practices
  • Abstract Number: 0937
    MRL-lpr Mice Display Altered Nociception: A new model for lupus peripheral neuropathy
  • Abstract Number: 0009
    MRT-6160, a VAV1-Directed Molecular Glue Degrader, Attenuates T and B Cell Effector Functions and Inhibits Disease Progression in a Spontaneous MRL-Faslpr Mouse Model
  • Abstract Number: 0991
    MTHFD2 is a Novel Metabolic Target in Autoimmune Disease
  • Abstract Number: 0829
    Multi-Center Use of an Online Case-Based Simulation to Evaluate Medical Trainee Use of Diagnostic Imaging and Lab Tests to Correctly Diagnose MSK Complaints
  • Abstract Number: 2572
    Multi-Modal Machine Learning Prediction and Phenotyping of Systemic Lupus Erythematosus Using Longitudinal EHR and Genomic Data from the All of Us Program
  • Abstract Number: 1736
    Multi-Model Evaluation of the Impact of CD14 on Synovial Inflammation and Pain During PTOA.
  • Abstract Number: 1755
    Multi-Omic Profiling Of CD8+ T Cells In Axial Spondyloarthritis (axSpA) And Reactive Arthritis (ReA) Implicates Common Pathways
  • Abstract Number: 0957
    Multi-Omic Profiling Reveals a Monocyte-Vascular Signature Associated with the Regression of Skin Fibrosis in SSc
  • Abstract Number: 1114
    Multi-omics Integration Analysis of the Cross-scale Mechanism of MTX-induced T2DM Risk and the Precise Intervention Strategy of Leonurine
  • Abstract Number: 2589
    Multi-omics Integration Reveals Gut Microbiota–Metabolite Dysregulation in Gout with Metabolic Syndrome
  • Abstract Number: 1796
    Multi-Tissue Molecular and Histopathological Profiling of Facet Joints and Intervertebral Discs
  • Abstract Number: 0268
    Multicenter study and literature review of JAK inhibitor treatment in refractory uveitis due to different immune-mediated inflammatory pathologies
  • Abstract Number: 0485
    Multicenter study on the use of Upadacitinib: Results in RA patients previously treated with Baricitinib
  • Abstract Number: 2350
    Multicenter study on the use of Upadacitinib: sex specific results in Spondyloarthritis
  • Abstract Number: 0295
    Multidimensional Analysis of Fatigue in Idiopathic Inflammatory Myopathies: Clinical, Psychological, and Sociodemographic Determinants
  • Abstract Number: 1414
    Multidimensional Assessment to Differentiate Early Psoriatic Arthritis from Cutaneous Psoriasis
  • Abstract Number: 0380
    Multidimensional Health Assessment Questionnaire (MDHAQ)/RAPID3, is an Useful Tool to Assess Comorbid and Residual Fatigue in Rheumatoid Arthritis Patients
  • Abstract Number: 2108
    Multidisciplinary Fragility Fracture Management Across Two Coordinated Hospitals: Evaluating Risk Factors, Treatment Approaches, and Long-Term Patient Outcomes in Those With and Without Prior Fractures
  • Abstract Number: 2142
    Multidisciplinary Rheumatology Transition Clinic for Young Adults Shows Improved Experience, Utilization, and Health Maintenance: A Mixed-Methods Evaluation
  • Abstract Number: 2684
    Multimodal Analysis Revealed Altered Brain Connectivity Patterns and Neuroinflammatory Processes in the Background of Difficult-To-Treat Rheumatoid Arthritis
  • Abstract Number: 0705
    Multimodal Imaging Evaluation of Patients with Raynaud’s Phenomenon meeting the Criteria for “Early” Systemic Sclerosis according to LeRoy versus Healthy Controls: a Prospective Cross-sectional study
  • Abstract Number: 1784
    Multimodal Preclinical Screening Of Glucocorticoid-Induced Disruption Of Bone Remodeling In Rat
  • Abstract Number: 1362
    Multimodal Spatial and Single-Cell Profiling of Synovial Tissue Reveals Macrophage Programs Associated with Biologic TherapyTreatment Response in Rheumatoid Arthritis
  • Abstract Number: 0546
    Multimorbidity clusters in psoriatic arthritis, psoriasis, and axial spondyloarthritis and their association with healthcare utilization: A population-based study
  • Abstract Number: 1829
    Multiomic Investigation of Juvenile Idiopathic Arthritis Synovium Reveals Immune Cell Heterogeneity
  • Abstract Number: 2091
    Multiplanar MRI Quantification of Effusion-Synovitis: Reliability and Potential Investigative Utility for Inflammation-Mediated Knee Conditions
  • Abstract Number: 1944
    Musculoskeletal Ultrasound Clinic Referral Patterns and Joint Findings in a Tertiary Care Center amongst Patients with Elevated BMI and Inflammatory Arthritis
  • Abstract Number: 0385
    Musculoskeletal Ultrasound Enhances Patient Insight and Clinical Decisions: A Multi-Center Study
  • Abstract Number: 2579
    Mutant COPA Permits Aberrant NETosis and Exacerbates Autoimmune Lung Disease
  • Abstract Number: PP03
    My Journey of Risk, Loss, and Hope: The Role of Multidisciplinary Collaboration in Managing Pregnancy with Takayasu Arteritis
  • Abstract Number: 0863
    Myeloid Dendritic Cell Subsets Characterize Muscle of Inclusion Body Myositis Patients and Correlate with KLRG1+ and TBX21+ CD8+ T cells
  • Abstract Number: 1246
    Myo Vs. Myo-fascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial
  • Abstract Number: 0999
    Myositis Induced by Histidyl-Transfer tRNA Synthetase is Exacerbated by Membranopathy and Suppressed by Regulatory T Cells
  • Abstract Number: 1187
    Myositis-Specific Antibody Profiles and Factors Associated With Rapidly Progressive Interstitial Lung Disease and Mortality in Antisynthetase Syndrome: A Systematic Review and Meta-Analysis
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology